TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Kivo Health raised $10 million in a Series A round led by Allumia Ventures, taking its total financing to $16 million. The Seattle company plans to expand its virtual care program for people with COPD nationwide and says it aims to reach tens of thousands of patients in two years.
Seattle-based Kivo Health has raised $10 million in Series A financing to expand its virtual home-care services for people with chronic lung disease, the company said. The round brings its total financing to $16 million and is intended to support a nationwide expansion, starting with care for chronic obstructive pulmonary disease, or COPD.
Allumia Ventures led the round, with additional investment from Corewell Health Ventures, Y Combinator, Heuristic Capital and MassMutual Ventures, according to Home Health Care News. The report did not disclose the funding terms or how the investment was divided among participants.
Kivo’s program combines virtual respiratory therapy with equipment and treatment plans for use at home. After enrolling, patients receive a kit that includes a tablet, an oxygen monitor and exercise bands. They meet virtually with a respiratory therapist for an initial assessment and personalized plan, then attend small-group sessions twice weekly for nine weeks, according to the company’s website.
The sessions cover breathing techniques, targeted exercises and resources for managing COPD. Kivo says its approach is designed to help patients manage symptoms between clinical visits and receive earlier intervention. Those descriptions reflect the company’s stated aims; the source report does not provide independent clinical or financial outcome data for the program.
Funding to Extend Home COPD Care
The financing gives Kivo additional capital to pursue geographic growth in a care model that moves respiratory support into patients’ homes and supplements clinical visits. If the planned expansion proceeds, more patients and health plans may have access to structured virtual therapy for COPD, though the company has not named specific new markets or a rollout schedule.
Kivo co-founder and CEO Victor Sadauskas told Home Health Care News that the company aims to serve tens of thousands of patients over the next two years. He also said the program has delivered tens of thousands of sessions and that it reduces avoidable hospitalizations, emergency-room visits and nursing-home days. These are company-reported claims; the article did not include the underlying data or an independent evaluation.
The company says it reduces total health-care spending by $8,245 per member per year, attributing the savings to fewer hospitalizations, emergency visits and nursing-home days. That figure is a Kivo claim, and the source report does not specify the measurement period, comparison group or methodology. Those details matter to insurers and patients weighing the program’s results against its costs.
Products Worth Considering
KitchenAid Artisan 5-Quart Tilt-Head Stand Mixer, Almond Cream
KitchenAid Classic Series 4.5 Quart Tilt-Head Stand Mixer K45SS, Onyx Black
Ninja Professional XL Food Processor, 12-Cup, 1200 Peak Watts, NF701
As an affiliate, we earn on qualifying purchases.
How Kivo’s Program Works
Kivo focuses on chronic obstructive pulmonary disease, a long-term lung condition, and describes its service as AI-powered virtual home care. The reported program includes a home kit, an assessment with a respiratory therapist and a nine-week course of twice-weekly group sessions. The source material does not explain how artificial intelligence is used in care delivery or what clinical decisions, if any, it supports.
The company says its program is covered by Medicare, Medicaid and several commercial health plans, including UnitedHealthcare, Humana, Blue Cross, Aetna and Priority Health. Coverage can depend on plan and eligibility; the report does not give details on patient costs or the terms of individual insurance arrangements.
Kivo’s stated plans extend beyond its current COPD focus. In addition to expanding across the country, it intends to adapt its care model for other high-cost chronic illnesses. The company has not identified which conditions it may address or when it expects to launch any additional programs.
“We plan to expand nationwide to deliver care to tens of thousands of patients in the next two years.”
— Victor Sadauskas, Kivo Health co-founder and CEO, speaking to Home Health Care News
Outcome Data and Rollout Details
The funding announcement provides no breakdown of how the $10 million will be spent, the financing terms, or a timetable for Kivo’s expansion. It is also unclear which regions the company will enter first and how quickly it can add patients while maintaining its current care model.
The source report does not provide independent evidence for Kivo’s claims about symptom improvement, reduced health-care spending or fewer hospital and nursing-home visits. Details behind the stated $8,245 annual savings per member—including the comparison baseline, time period and calculation method—are not provided. The role of AI in the service and plans for care beyond COPD also remain unspecified.
Kivo’s Planned Expansion
Kivo says it will use the financing to expand nationwide and plans to provide care to tens of thousands of patients within two years. The company has not yet announced specific locations, intermediate enrollment targets or dates for expansion into other conditions.
Further details on where the service will become available, how insurance coverage will apply in new markets and what evidence supports the reported outcomes would help clarify the scope and likely effect of the expansion.
Key Questions
How much funding did Kivo Health raise?
Kivo raised $10 million in a Series A round, bringing its total financing to $16 million, according to Home Health Care News.
Who led the Series A round?
Allumia Ventures led the round. Corewell Health Ventures, Y Combinator, Heuristic Capital and MassMutual Ventures also participated, the report said.
What care does Kivo Health provide?
Kivo offers a virtual home-care program focused on COPD. It includes a home kit and virtual respiratory therapy, with group sessions twice a week for nine weeks, according to the company’s website.
What will Kivo do with the funding?
The company says the funding will support nationwide expansion. It also intends to adapt its care model to other high-cost chronic illnesses, but has not named those conditions or provided a launch schedule.
Are Kivo’s savings claims independently verified?
The source report attributes the claim of $8,245 in annual savings per member to Kivo. It does not include an independent evaluation or details about the calculation and comparison baseline.
Source: homehealthcarenews.com
